“Assessment of Dapagliflozin Effectiveness As Add-on Therapy for the Treatment of Type 2 Diabetes Mellitus ”. Academia Journal of Medicine 4, no. 2 (December 30, 2021): 50–54. Accessed May 7, 2025. https://www.journals.acspublisher.com/index.php/ajm/article/view/18812.